ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MEDS vs ZSTK // RETURN ON INVESTED CAPITAL (ROIC)

DataMeds AI Inc. (NASDAQ) VS. ZeroStack Corp. (NASDAQ) • 15-METRIC TALLY: MEDS 2 — ZSTK 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MEDS VS. ZSTK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MEDS ZSTK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -27.50% 4.60% -32.10 ZSTK /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -13.77% — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 28.70% -0.50% +29.20 MEDS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 41.1 30.3 +10.80 MEDS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $9.8M $63.9M -$54.2M ZSTK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MEDS REV ZSTK REV MEDS GROSS % ZSTK GROSS % MEDS FCF ZSTK FCF
FY 2025 $23.3M $35.7M -27.5% 4.6% -$10.9M -$8.8M
FY 2024 $18.1M $35.9M 9.7% 6.1% -$1.2M -$5.2M
FY 2023 $0 $76.1M — — -$349.1K -$8.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MEDS // BETA —
ZSTK // BETA —